| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | López Cortés, Luis |
| dc.contributor.author | Luque-Pardos, Sonia |
| dc.contributor.author | Fernandez Polo, Aurora |
| dc.contributor.author | Herrera Hidalgo, Laura |
| dc.contributor.author | de Alarcón González, Arístides |
| dc.contributor.author | Fernández-Rubio, Beatriz |
| dc.contributor.author | Luque-Marquez, Rafael |
| dc.date.accessioned | 2023-04-05T10:29:40Z |
| dc.date.available | 2023-04-05T10:29:40Z |
| dc.date.issued | 2023-03 |
| dc.identifier.citation | Fernández-Rubio B, Herrera-Hidalgo L, Luque-Márquez R, de Alarcón A, López-Cortés LE, Luque-Pardos S, et al. Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy. Antibiotics. 2023 Mar;12(3):432. |
| dc.identifier.issn | 2079-6382 |
| dc.identifier.uri | https://hdl.handle.net/11351/9308 |
| dc.description | Ampicilina; Endocarditis infecciosa; Terapia antimicrobiana parenteral ambulatoria |
| dc.language.iso | eng |
| dc.publisher | MDPI |
| dc.relation.ispartofseries | Antibiotics;12(3) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Medicaments antibacterians - Ús terapèutic |
| dc.subject | Endocarditis bacteriana - Tractament |
| dc.subject.mesh | Endocarditis, Bacterial |
| dc.subject.mesh | /drug therapy |
| dc.subject.mesh | Anti-Bacterial Agents |
| dc.subject.mesh | /therapeutic use |
| dc.title | Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3390/antibiotics12030432 |
| dc.subject.decs | endocarditis bacteriana |
| dc.subject.decs | /farmacoterapia |
| dc.subject.decs | antibacterianos |
| dc.subject.decs | /uso terapéutico |
| dc.relation.publishversion | https://doi.org/10.3390/antibiotics12030432 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Fernández-Rubio B] Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Herrera-Hidalgo L] Unidad de Gestión Clínica de Farmacia, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. Unidad de Gestión Clinica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Luque-Márquez R, de Alarcón A] Unidad de Gestión Clinica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [López-Cortés LE] Infectious Diseases and Microbiology Clinical Unit, University Hospital Virgen Macarena, Departament of Medicine, School of Medicine, University of Sevilla, Biomedicine Institute of Sevilla (IBiS)/CSIC, Seville, Spain. Centro de Investigación en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. [Luque-Pardos] Unidad de Gestión Clínica de Farmacia, Hospital del Mar, Barcelona, Spain. [Fernández-Polo A] Servei de Farmàcia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
| dc.identifier.pmid | 36978299 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |